NCM 106 Pharmacology: Comprehensive Lecture Review

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/67

flashcard set

Earn XP

Description and Tags

Comprehensive vocabulary flashcards covering the eight core modules of NCM 106 Pharmacology: cardiovascular, respiratory, muscular, gastrointestinal, urinary, endocrine, antimicrobial, and obstetric/gynecologic drug therapies.

68 Terms

1
New cards

Antihypertensives

Medications indicated to lower blood pressure, including drug classes such as ACE inhibitors, ARBs, alpha blockers, beta blockers, calcium channel blockers, and diuretics.

2
New cards

Angiotensin-Converting Enzyme (ACE) Inhibitors

Antihypertensive agents that lower blood pressure by preventing the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor (e.g., Lisinopril, Ramipril, Enalapril).

3
New cards

Angiotensin II Receptor Blockers (ARBs)

Antihypertensive agents that lower blood pressure by blocking angiotensin II from binding to receptors, preventing blood vessels from tightening (e.g., Losartan, Valsartan, Telmisartan).

4
New cards

Alpha Blockers

Antihypertensive medications that lower systemic blood pressure by relaxing artery wall muscles (e.g., Prazosin, Doxazosin).

5
New cards

Cardiotonic Agents

Medications that exert a strengthening effect on the myocardium or increase cardiac output, comprising cardiac glycosides and sympathomimetics.

6
New cards

Cardiac Glycosides

Cardiotonic agents that increase myocardial efficiency and contractile force while decreasing heart rate; indicated for congestive heart failure and arrhythmias (e.g., Digoxin).

7
New cards

Sympathomimetic Drugs

Cardiotonic agents that mimic sympathetic nervous system stimulation to engage fight-or-flight responses; indicated for anaphylaxis, cardiac arrest, shock, and hypotension (e.g., Epinephrine, Isoproterenol, Ephedrine).

8
New cards

Phosphodiesterase Inhibitors

Medications that cause vascular smooth muscle to relax and dilate, improving systemic circulation and reducing blood pressure; used in decompensated heart failure and pulmonary hypertension (e.g., Milrinone).

9
New cards

Antiarrhythmic Drugs

Pharmacologic agents used to prevent and manage excessively fast or irregular cardiac rhythms (arrhythmias).

10
New cards

Class I Antiarrhythmics (Sodium Channel Blockers)

Vaughan-Williams antiarrhythmic agents that inhibit the influx of sodium ions across cardiac cell membranes (e.g., Quinidine, Lidocaine, Flecainide).

11
New cards

Class II Antiarrhythmics (Beta Blockers)

Vaughan-Williams antiarrhythmic agents that decrease heart rate by antagonizing adrenergic hormones like adrenaline (e.g., Propranolol, Metoprolol, Atenolol).

12
New cards

Class III Antiarrhythmics (Potassium Channel Blockers)

Vaughan-Williams antiarrhythmic agents that impede potassium movement through cell membranes, prolonging repolarization (e.g., Amiodarone, Sotalol).

13
New cards

Class IV Antiarrhythmics (Nondihydropyridine Calcium Channel Blockers)

Vaughan-Williams antiarrhythmic agents that block L-type calcium channels in cardiac tissue, reducing heart rate and myocardial contractility (e.g., Diltiazem, Verapamil).

14
New cards

Antianginal Drugs

Medications used to prevent or alleviate chest pain caused by myocardial ischemia, functioning by reducing cardiac workload or myocardial oxygen demand.

15
New cards

Nitrates

Antianginal vasodilators that decrease cardiac preload and workload to relieve ischemic chest pain (e.g., Nitroglycerin, Isosorbide dinitrate).

16
New cards

Statins

Lipid-lowering agents that inhibit HMG-CoA reductase, decreasing hepatic cholesterol synthesis and upregulating LDL clearance (e.g., Atorvastatin, Rosuvastatin).

17
New cards

Ezetimibe

A lipid-lowering medication categorized as a cholesterol absorption inhibitor that selectively reduces intestinal absorption of dietary and biliary cholesterol.

18
New cards

Fibrates

Lipid-lowering agents that activate PPAR-α to primarily reduce circulating triglyceride levels (e.g., Fenofibrate, Gemfibrozil).

19
New cards

Anticoagulants

Coagulation-modifying drugs that inhibit clot formation by interfering with various steps of the clotting cascade; indicated for DVT, PE, and thromboembolism prevention (e.g., Heparin, Warfarin, Rivaroxaban).

20
New cards

Antiplatelets

Coagulation-modifying medications that inhibit platelet aggregation to prevent thrombus formation in arterial disease, acute MI, or ischemic stroke (e.g., Aspirin, Clopidogrel).

21
New cards

Thrombolytics

Fibrinolytic drugs that activate the conversion of plasminogen to plasmin to dissolve pre-existing blood clots in acute ischemic stroke, myocardial infarction, or pulmonary embolism (e.g., Alteplase, Tenecteplase).

22
New cards

Iron Preparations (Hematinics)

Supplemental medications that replenish elemental iron stores required for hemoglobin synthesis and red blood cell production in iron-deficiency anemia (e.g., Ferrous sulfate, Ferrous gluconate).

23
New cards

Erythropoiesis-Stimulating Agents (ESAs)

Biologic agents that stimulate bone marrow erythroid progenitor cells to increase red blood cell production in anemia of chronic kidney disease (e.g., Epoetin alfa).

24
New cards

Bronchodilators

Respiratory medications that relax bronchial smooth muscle, dilating the airways to manage bronchospasm in asthma and COPD (e.g., Albuterol).

25
New cards

Inhaled Corticosteroids

Anti-inflammatory respiratory agents that suppress airway mucosal inflammation and edema to control long-term asthma symptoms (e.g., Budesonide, Fluticasone).

26
New cards

Leukotriene Modifiers

Oral agents used for chronic maintenance of asthma and allergic rhinitis that antagonize leukotriene-mediated bronchoconstriction and inflammation (e.g., Montelukast).

27
New cards

Antihistamines

Histamine receptor antagonists that alleviate allergy symptoms like rhinorrhea, sneezing, and pruritus; categorized into sedating first-generation (e.g., Diphenhydramine) and non-sedating second-generation agents (e.g., Cetirizine).

28
New cards

Decongestants

Sympathomimetic agents that reduce nasal passage edema and vascular congestion by constricting dilated mucosal arterioles (e.g., Pseudoephedrine).

29
New cards

Antitussives

Centrally or locally acting pharmacologic agents indicated to suppress dry, nonproductive coughs (e.g., Dextromethorphan, Codeine).

30
New cards

Expectorants

Medications that thin respiratory secretions and stimulate flow, making thick, productive mucus easier to evacuate from the bronchial tree (e.g., Guaifenesin).

31
New cards

Mucolytics

Agents that enzymatically or chemically disrupt the disulfide bonds of mucus to decrease secretion viscosity for easier expectoration (e.g., Acetylcysteine).

32
New cards

Spasticity

A motor disorder characterized by involuntary, velocity-dependent muscle contraction or hypertonia caused by upper motor neuron damage within the brain or spinal cord.

33
New cards

Antispastic Muscle Relaxants

Centrally or peripherally acting agents prescribed to manage hypertonicity and involuntary contractions caused by neurological disorders (e.g., Baclofen, Dantrolene).

34
New cards

Antispasmodic Muscle Relaxants

Medications indicated primarily to alleviate acute musculoskeletal pain, muscle spasms, and myofascial strain (e.g., Carisoprodol, Chlorzoxazone, Cyclobenzaprine).

35
New cards

Dual-Action Muscle Relaxants

Skeletal muscle relaxants that possess both antispastic and antispasmodic clinical activity (specifically Tizanidine and Diazepam).

36
New cards

Neuromuscular Blockers

Pharmacologic paralytics that block transmission at the neuromuscular junction to temporarily abolish skeletal muscle contraction during endotracheal intubation or surgical procedures (e.g., Cisatracurium, Rocuronium).

37
New cards

Drug-Induced Esophagitis

Direct chemical injury and mucosal inflammation of the esophagus occurring when an ingested tablet or capsule becomes physically lodged in the esophageal lumen.

38
New cards

Antiemetics

Medications formulated to prevent or relieve nausea and emesis by targeting specific receptors in the chemoreceptor trigger zone and gastrointestinal tract.

39
New cards

5-HT35\text{-HT}_3 Receptor Antagonists

Antiemetic agents that competitively block serotonin receptors in the peripheral vagal nerve terminals and the chemoreceptor trigger zone; effective for cytotoxic chemotherapy-induced nausea (e.g., Hyoscine context).

40
New cards

Prokinetics (Dopamine Antagonists)

GI medications that block dopamine receptors to stimulate gastrointestinal motility, accelerate gastric emptying, and suppress emesis.

41
New cards

Emetics

Substances that stimulate the central chemoreceptor trigger zone and gastric mucosal receptors to therapeutically induce vomiting (e.g., Apomorphine, Copper Sulfate).

42
New cards

Osmotic Laxatives

Purgatives containing nonabsorbable solutes that draw water into the intestinal lumen by osmotic force, increasing stool mass and triggering peristalsis (e.g., Magnesium hydroxide).

43
New cards

Antacids

Alkaline compounds that chemically neutralize existing gastric hydrochloric acid, increasing intragastric pH and protecting the mucosa (e.g., Sodium bicarbonate).

44
New cards

Proton Pump Inhibitors (PPIs)

Acid-suppressing agents that irreversibly inactivate the H+/K+H^+/K^+ ATPase enzyme system—the final common pathway of gastric acid production (e.g., Omeprazole, Lansoprazole).

45
New cards

Antidiarrheals

Medications that stimulate peripheral opioid receptors in the GI tract to decrease propulsive motility and enhance intestinal fluid absorption (e.g., Loperamide, Diphenoxylate).

46
New cards

Histamine-2 (H2H_2) Receptor Antagonists

Antiulcer agents that competitively block histamine receptors on gastric parietal cells to decrease basal and stimulated gastric acid output (e.g., Cimetidine, Ranitidine).

47
New cards

Loop Diuretics

Potent natriuretic diuretics that act on the ascending loop of Henle to cause substantial fluid and sodium excretion (e.g., Furosemide).

48
New cards

Potassium-Sparing Diuretics

Diuretic agents that promote renal sodium and water clearance while conserving potassium ions in the distal nephron (e.g., Spironolactone).

49
New cards

Urinary Tract Analgesic

A compound that exerts a direct topical analgesic/anesthetic effect on inflamed urinary mucosa to alleviate dysuria, urgency, and burning without antibacterial properties (e.g., Phenazopyridine).

50
New cards

Bladder Stimulant

A cholinergic agonist that stimulates parasympathetic muscarinic receptors to force detrusor muscle contraction and facilitate bladder emptying (e.g., Bethanechol).

51
New cards

Desmopressin

A synthetic analogue of antidiuretic hormone (ADH) that enhances renal fluid conservation to treat central diabetes insipidus, nocturnal enuresis, and hemophilia A.

52
New cards

Somatropin

A recombinant form of human growth hormone that stimulates skeletal and somatic tissue growth in pediatric growth hormone deficiencies.

53
New cards

Levothyroxine

A synthetic thyroid hormone (T4) replacement used to treat clinical hypothyroidism and regulate cellular metabolic rate.

54
New cards

Methimazole

An antithyroid drug that inhibits thyroid peroxidase to reduce excessive thyroid hormone synthesis in hyperthyroidism and Graves' disease.

55
New cards

Metformin

A first-line oral biguanide antidiabetic drug that reduces hepatic gluconeogenesis and enhances peripheral tissue sensitivity to insulin.

56
New cards

Alendronate

An oral bisphosphonate that inhibits osteoclast-mediated bone resorption to prevent bone loss in postmenopausal or age-related osteoporosis.

57
New cards

Bactericidal

A classification of antimicrobial agent that directly kills bacterial cells (e.g., Penicillin).

58
New cards

Bacteriostatic

A classification of antimicrobial agent that arrests the growth and replication of bacteria, relying on host immunity for clearance (e.g., Azithromycin).

59
New cards

Uterotonic Agents

Medications that induce or augment myometrial contractions to initiate labor or control postpartum hemorrhage (e.g., Oxytocin, Misoprostol, Carboprost).

60
New cards

Oxytocin

A peptide uterotonic hormone indicated to induce or augment uterine contractions during labor and control uterine atony after delivery.

61
New cards

Carboprost

A prostaglandin F2αF_{2\alpha} analogue uterotonic that produces intense myometrial contractions to manage refractory postpartum hemorrhage.

62
New cards

Antihemorrhagic Agents

Systemic or topical hemostatic medications designed to arrest acute hemorrhage by enhancing physiological clotting mechanisms or constricting local vessels.

63
New cards

Magnesium Sulfate (Obstetric)

A central nervous system depressant and anticonvulsant administered intravenously to prevent and control eclamptic seizures in preeclampsia.

64
New cards

Calcium Gluconate

The specific intravenous antidote administered to counteract life-threatening neuromuscular depression and cardiotoxicity induced by magnesium sulfate overdose.

65
New cards

Tocolytic Agents

Medications that inhibit myometrial contractions to delay preterm labor by 24 to 48 hours24\text{ to }48\text{ hours}, allowing time for fetal lung maturation via antenatal corticosteroids (e.g., Terbutaline, Nifedipine).

66
New cards

Terbutaline

A beta-2 adrenergic agonist tocolytic that relaxes uterine smooth muscle to arrest premature contractions.

67
New cards

Ovulation-Inducing Agents

Pharmacologic treatments (e.g., Letrozole, Clomiphene citrate) that stimulate follicular maturation and ovarian egg release in ovulatory dysfunction or PCOS-related infertility.

68
New cards

Mifepristone

A selective antiprogestogen medication that blocks the action of progesterone to terminate intrauterine pregnancy up to 10 to 12 weeks10\text{ to }12\text{ weeks} of gestation when followed by misoprostol.